Project Number GC-2013807 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2018 View Full Project Details for A Phase IIa Trial to Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of TW001 in Alzheimer Patients Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) g. Oxidative Stress Researcher and Organization Principal Investigator van der Geest, Ronald Principal Investigator First Name Ronald Principal Investigator Last Name van der Geest Awardee Organization Treeway B.V. Contact PI Country The Netherlands Project Detail Funding Opportunity Announcement Program to Accelerate Clinical Trials (PACT) RFP FY Overall Cost $2,994,122 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
